Histone methyltransferase Suv39h1 deficiency prevents Myc-induced chromosomal instability in murine myeloid leukemias

Genes Chromosomes and Cancer

Volumn 52, Issue 4, 2013, Pages 423-430

  Vajen, Beate ^a   Modlich, Ute ^a   Schienke, Andrea ^a   Wolf, Susanne ^a   Skawran, Britta ^a   Hofmann, Winfried ^a   Büsche, Guntram ^a   Kreipe, Hans ^a   Baum, Christopher ^a   Santos Barriopedro, Irene ^b   Vaquero, Alejandro ^b,c   Schlegelberger, Brigitte ^a   Rudolph, Cornelia ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE METHYLTRANSFERASE; MYC PROTEIN; SUV38H1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; CHROMOSOME; GENE EXPRESSION; KARYOTYPE; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; TELOMERE; WILD TYPE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHROMOSOMAL INSTABILITY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GREEN FLUORESCENT PROTEINS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; MALE; METHYLTRANSFERASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTRAL KARYOTYPING; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

MURINAE; MUS;

EID: 84873735482     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22040     Document Type: Article

References (30)

1. Aubert G, Hills M, Lansdorp P. 2012. Telomere length measurement-Caveats and a critical assessment of the available technologies and tools. Mutat Res 1: 59-67.
2. Blasco MA. 2005. Telomeres and human disease: Ageing, cancer and beyond. Nat Rev Genet 6: 611-622.
3. Blasco MA. 2007. The epigenetic regulation of mammalian telomeres. Nat Rev Genet 8: 299-309.
4. Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Lüscher B. 2001. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 15: 2042-2047.
5. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T, Schmitt CA. 2005. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665.
6. Bullinger L, Döhner K, Bair E, Fröhling S, Schlenk RF, Tibshirani R, Döhner H, Pollack JR. 2004. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350: 1605-1616.
7. Bullinger L, Ehrich M, Döhner K, Schlenk RF, Döhner H, Nelson MR, van den Boom D. 2010. Quantitative DNA methylation predicts survival in adult acute myeloid leukemia. Blood 115: 636-642.
8. Faiola F, Liu X, Lo S, Pan S, Zhang K, Lymar E, Farina A, Martinez E. 2005. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol Cell Biol 25: 10220-10234.
9. Fan Q, Zhang F, Barrett B, Ren K, Andreassen PR. 2009. A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res 37: 1740-1754.
10. Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston DM, Amati B. 2003. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4: 575-580.
11. Garcia-Cao M, O'Sullivan R, Peters AH, Jenuwein T, Blasco MA. 2004. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 36: 94-99.
12. Greiner J, Schmitt M, Li L, Giannopoulos K, Bosch K, Schmitt A, Dohner K, Schlenk RF, Pollack JR, Dohner H, Bullinger L. 2006. Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches. Blood 108: 4109-4117.
13. Guffei A, Lichtensztejn Z, Goncalves Dos Santos Silva A, Louis SF, Caporali A, Mai S. 2007. c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells. Neoplasia 9: 578-588.
14. Hemann MT, Strong MA, Hao LY, Greider CW. 2001. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107: 67-77.
15. Li Q, Dang CV. 1999. c-Myc overexpression uncouples DNA replication from mitosis. Mol Cell Biol 19: 5339-5351.
16. Li Z, Schwieger M, Lange C, Kraunus J, Sun H, van den Akker E, Modlich U, Serinsöz E, Will E, von Laer D, Stocking C, Fehse B, Schiedlmeier B, Baum C. 2003. Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose. Exp Hematol 31: 1206-1214.
17. Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Lichtensztejn Z, Kuttler F, Chuang TC, Moshir S, Mougey V, Chuang AY, Kerr PD, Fest T, Boukamp P, Mai S. 2005. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 102: 9613-9618.
18. McClintock B. 1984. The significance of responses of the genome to challenge. Science 226: 792-801.
19. Nabetani A and Ishikawa F. 2011. Alternative lengthening of telomeres pathway: Recombination-mediated telomere maintenance mechanism in human cells. J Biochem 149: 5-14.
20. Pampalona J, Soler D, Genesca A, Tusell L. 2010. Whole chromosome loss is promoted by telomere dysfunction in primary cells. Genes Chromosomes Cancer 49: 368-378.
21. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, Jenuwein T. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107: 323-337.
22. Potts PR, Yu H. 2007. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat Struct Mol Biol 14: 581-590.
23. Reimann M, Lee S, Loddenkemper C, Dörr JR, Tabor V, Aichele P, Stein H, Dörken B, Jenuwein T, Schmitt CA. 2010. Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. Cancer Cell 17: 262-272.
24. Rudolph C, Schlegelberger B. 2009. Spectral karyotyping and fluorescence in situ hybridization of murine cells. Methods Mol Biol 506: 453-466.
25. Schambach A, Galla M, Modlich U, Will E, Chandra S, Reeves L, Colbert M, Williams DA, von Kalle C, Baum C. 2006. Lentiviral vectors pseudotyped with murine ecotropic envelope: Increased biosafety and convenience in preclinical research. Exp Hematol 34: 588-592.
26. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550.
27. Uhlírová R, Horáková AH, Galiová G, Legartová S, Matula P, Fojtová M, Varecha M, Amrichová J, Vondrácek J, Kozubek S, Bártová E. 2010. SUV39h- and A-type lamin-dependent telomere nuclear rearrangement. J Cell Biochem 109: 915-926.
28. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. 2002. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability. Mol Cell 9: 1031-1044.
29. Zeng SJ, Lin YT, Tian CP, Song KJ, Zhang XW, Zuo MX. 2009. Evolutionary significance of delayed neurogenesis in the core versus shell auditory areas of Mus musculus. J Comp Neurol 515: 600-613.
30. Zhong ZH, Jiang WQ, Cesare AJ, Neumann AA, Wadhwa R, Reddel RR. 2007. Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J Biol Chem 282: 29314-29322.